ResearchGreat debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaques
May 11, 2026LetterCurrent Incidence and Modality of Young Aortic Valve Replacement in the United States.Written by 1 Roon author & 4 others Via The American Heart Association Journals
ResearchExpert perspectives on tricuspid repair | replacement | medical therapy - Beyond the Guidelines: Insights from the Cardiovascular Research Technologies 2026 meeting
ResearchExpert perspectives on de-escalation of antiplatelet therapy - Beyond the Guidelines: Insights from the Cardiovascular Research Technologies 2026 meeting
ResearchEmerging Longer-Term Evidence on Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis in Low-Risk Patients: A Call for Caution
ResearchUnentangling Heart Failure From Kidney Outcomes With Finerenone: Insights From the FINEARTS-HF Trial